Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000637109 | SCV000758557 | likely benign | Epileptic encephalopathy | 2024-11-26 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004659136 | SCV005158876 | uncertain significance | not specified | 2024-05-26 | criteria provided, single submitter | clinical testing | The c.11815A>G (p.I3939V) alteration is located in exon 89 (coding exon 89) of the RYR3 gene. This alteration results from a A to G substitution at nucleotide position 11815, causing the isoleucine (I) at amino acid position 3939 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |